Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Becton, Dickinson and Co's Total Stockholders Equity for the quarter that ended in Jun. 2022 was $25,494 Mil. Becton, Dickinson and Co's Total Assets for the quarter that ended in Jun. 2022 was $53,199 Mil.
Therefore, Becton, Dickinson and Co's Equity to Asset Ratio for the quarter that ended in Jun. 2022 was 0.48.
The historical rank and industry rank for Becton, Dickinson and Co's Equity-to-Asset or its related term are showing as below:
BDX'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25 Med: 0.46 Max: 0.63
Current: 0.48
During the past 13 years, the highest Equity to Asset Ratio of Becton, Dickinson and Co was 0.63. The lowest was 0.25. And the median was 0.46.
BDX's Equity-to-Asset is ranked worse than 72.29% of 848
companies
in the Medical Devices & Instruments industry
Industry Median: 0.67
vs BDX: 0.48
Becton, Dickinson and Co Equity-to-Asset Historical Data
The historical data trend for Becton, Dickinson and Co's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Becton, Dickinson and Co Annual Data
Trend
Sep12
Sep13
Sep14
Sep15
Sep16
Sep17
Sep18
Sep19
Sep20
Sep21
Equity-to-Asset
0.34
0.39
0.41
0.44
0.44
Becton, Dickinson and Co Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Equity-to-Asset
0.44
0.44
0.45
0.45
0.48
Competitive Comparison
For the Medical Instruments & Supplies subindustry, Becton, Dickinson and Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton, Dickinson and Co Equity-to-Asset Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Becton, Dickinson and Co's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Becton, Dickinson and Co's Equity-to-Asset falls into.
Becton, Dickinson and Co Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Becton, Dickinson and Co's Equity to Asset Ratio for the fiscal year that ended in Sep. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Becton, Dickinson and Co (NYSE:BDX) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Becton, Dickinson and Co Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Becton, Dickinson and Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.97(0.36%) Volume: 957,860 11:08PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:BDX has been successfully added to your 
